AI-driven etch/deposition demand drove fiscal Q4 2026 beat and Q1 FY2027 above-consensus guidance raise; semicap cycle intact; extreme oversold dislocation with fundamental beat creates clear entry.

Q4 FY2026: revenue $6.72B vs $6.65B consensus; EPS $1.82 vs $1.69. Q1 FY2027 guide $8.1B midpoint and EPS $2.15 midpoint — both raised above estimates. Tripwire HEALTHY (opposite of guide cut). Implied ~1.6x to pre-selloff analyst consensus (~$400) — formula gives low, but beat-and-raise will drive PT upgrades; category-typical medium for established semicap with execution clarity. Semicap & foundry sleeve on target at 15.6% (15–20% target), not overweight. Tech sector -41.76% 20d selloff is macro-driven; fundamentals confirm AI demand is accelerating. [red-team: holds]

AI-driven etch/deposition demand drove fiscal Q4 2026 beat and Q1 FY2027 above-consensus guidance raise; semicap cycle intact; extreme oversold dislocation with fundamental beat creates clear entry.